POST-AZACITIDINE CLONE SIZE PREDICTS LONG-TERM OUTCOME OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND RELATED MYELOID NEOPLASMS. (May 2023) - Nannya, Y.; Tobiasson, M.; Sato, S.; Bernard, E.; Ohtake, S.; Takeda, J.; Creignou, M.; Kusakabe, M.; Shibata, Y.; Nakamura, N.; Watanabe, M.; Hiramoto, N.; et al.